⌘K

Login Start Free

Home/Filings/4/0001179110-13-002286

4//SEC Filing

LACK WALTER J 4

Accession 0001179110-13-002286

CIK 0000919722other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:49 PM ET

Size

23.8 KB

Accession

0001179110-13-002286

Insider Transaction Report

Form 4

Period: 2013-02-06

Astex Pharmaceuticals, IncASTX

Director

Transactions

Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−2,500→ 0 total
Exercise: $3.97Exp: 2016-06-09→ Common Stock (2,500 underlying)
Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−10,000→ 0 total
Exercise: $2.92Exp: 2021-06-16→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2013-02-06$2.92/sh+10,000$29,200→ 457,500 total
Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−15,000→ 0 total
Exercise: $2.92Exp: 2021-06-16→ Common Stock (15,000 underlying)
Exercise/Conversion
Common Stock
2013-02-06$3.97/sh+2,500$9,925→ 417,500 total
Exercise/Conversion
Common Stock
2013-02-06$3.97/sh+2,500$9,925→ 422,500 total
Exercise/Conversion
Common Stock
2013-02-06$2.92/sh+10,000$29,200→ 447,500 total
Exercise/Conversion
Common Stock
2013-02-06$3.97/sh+2,500$9,925→ 420,000 total
Exercise/Conversion
Common Stock
2013-02-06$2.92/sh+15,000$43,800→ 437,500 total
Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−2,500→ 0 total
Exercise: $3.97Exp: 2016-06-09→ Common Stock (2,500 underlying)
Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−2,500→ 0 total
Exercise: $3.97Exp: 2016-06-09→ Common Stock (2,500 underlying)
Exercise/Conversion
Director Stock Option (Right to buy)
2013-02-06−10,000→ 0 total
Exercise: $2.92Exp: 2021-06-16→ Common Stock (10,000 underlying)

Footnotes (3)

[F1]2,500 shares of the 10,000 share option grant became exercisable on the June 9, 2006 grant date and on each three month anniversary thereafter.
[F2]3,750 shares of the 15,000 share option grant became exercisable on the June 16, 2011 grant date and on each three month anniversary therafter.
[F3]2,500 shares of the 10,000 share option grant became exercisable on the June 16, 2011 grant date and on each three month anniversary thereafter.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

Astex Pharmaceuticals, Inc

CIK 0000919722

Entity typeother

Related Parties

1

filerCIK 0001207708

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 4:49 PM ET
Size: 23.8 KB

View on SEC.gov